Verona Pharma | 4: Statement of changes in beneficial ownership of securities-Officer ZACCARDELLI DAVID
Verona Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Hahn Mark W
Verona Pharma | 144: Notice of proposed sale of securities pursuant to Rule 144
Verona Pharma | 144: Notice of proposed sale of securities pursuant to Rule 144
Verona Pharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Growth Equity Opportunities 17, LLC(6.9%),New Enterprise Associates 17, L.P.(6.9%), etc.
Verona Pharma | 4: Statement of changes in beneficial ownership of securities-Officer ZACCARDELLI DAVID
Verona Pharma | 4: Statement of changes in beneficial ownership of securities-Director EBSWORTH DAVID R
Verona Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Hahn Mark W
Verona Pharma | 144: Notice of proposed sale of securities pursuant to Rule 144
Verona Pharma | 144: Notice of proposed sale of securities pursuant to Rule 144
Verona Pharma | 4: Statement of changes in beneficial ownership of securities-Officer ZACCARDELLI DAVID
Verona Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Rickard Kathleen A.
Verona Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Hahn Mark W
Verona Pharma | 10-Q: Q2 2024 Earnings Report
Verona Pharma | 8-K: Verona Pharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update
Verona Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Hahn Mark W
Verona Pharma | 4: Statement of changes in beneficial ownership of securities-Officer ZACCARDELLI DAVID
Verona Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Rickard Kathleen A.
Verona Pharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Perceptive Advisors LLC(6.3%),Joseph Edelman(6.3%), etc.
Verona Pharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Deep Track Capital, LP(5.08%),Deep Track Biotechnology Master Fund, Ltd.(5.08%), etc.
No Data
No Data